Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

canadian-analyst-coverage-update:-july-29th,-2025

Canadian Analyst Coverage Update: July 29th, 2025

Jul 30, 2025

Analyst Ratings (Canada) AGF Management Ltd (AGF-B:CA) was rated “Hold” by Morningstar with a target price of $13.…

Read more
leading-analyst-firm-recognizes-diliko’s-“security-first”-data-management-platform-for-benefits-it-provides-midmarket-customers-in-regulated-industries

Leading Analyst Firm Recognizes Diliko’s “Security-First” Data Management Platform for Benefits it Provides Midmarket Customers in Regulated Industries

Jul 30, 2025

Leading Analyst Firm Recognizes Diliko’s “Security-First” Data Management Platform for Benefits it Provides Midmarket Customers in Regulated Industries…

Read more
hc-wainwright-assumes-coverage-on-aurinia-pharmaceuticals-stock-with-buy-rating-by-investing.com

H.C. Wainwright assumes coverage on Aurinia Pharmaceuticals stock with Buy rating By Investing.com

Jul 30, 2025

H.C. Wainwright assumes coverage on Aurinia Pharmaceuticals stock with Buy rating

Read more
canadian-analyst-coverage-update:-july-29th,-2025

Canadian Analyst Coverage Update: July 29th, 2025

Jul 30, 2025

Analyst Ratings (Canada) AGF Management Ltd (AGF-B:CA) was rated “Hold” by Morningstar with a target price of $13.…

Read more
analyst-coverage-sparks-interest-in-these-4-stocks-amid-volatility

Analyst Coverage Sparks Interest in These 4 Stocks Amid Volatility

Jul 30, 2025

In the current backdrop of heightened economic uncertainty—marked by tariff volatility, inflationary pressure, and growing concerns over policy…

Read more
top-analyst-reports-for-broadcom,-berkshire-hathaway-&-johnson-&-johnson

Top Analyst Reports for Broadcom, Berkshire Hathaway & Johnson & Johnson

Jul 30, 2025

Tuesday, July 29, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today’s…

Read more
raymond-james-assumes-coverage-on-bridgebio-stock-with-outperform-rating-by-investing.com

Raymond James assumes coverage on BridgeBio stock with Outperform rating By Investing.com

Jul 30, 2025

Raymond James assumes coverage on BridgeBio stock with Outperform rating

Read more
raymond-james-assumes-coverage-on-alnylam-stock-with-outperform-rating-by-investing.com

Raymond James assumes coverage on Alnylam stock with Outperform rating By Investing.com

Jul 29, 2025

Raymond James assumes coverage on Alnylam stock with Outperform rating

Read more
this-atai-life-sciences-analyst-begins-coverage-on-a-bullish-note;-here-are-top-4-initiations-for-tuesday-–-atai-life-sciences-(nasdaq:atai),-ionq-(nyse:ionq)

This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday – ATAI Life Sciences (NASDAQ:ATAI), IonQ (NYSE:IONQ)

Jul 29, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
jpmorgan-assumes-coverage-of-aris-water-solutions-stock-with-neutral-rating-by-investing.com

JPMorgan assumes coverage of Aris Water Solutions stock with Neutral rating By Investing.com

Jul 29, 2025

JPMorgan assumes coverage of Aris Water Solutions stock with Neutral rating

Read more
cantor-fitzgerald-assumes-coverage-on-avepoint-stock-with-overweight-rating-by-investing.com

Cantor Fitzgerald assumes coverage on Avepoint stock with Overweight rating By Investing.com

Jul 29, 2025

Cantor Fitzgerald assumes coverage on Avepoint stock with Overweight rating

Read more
clsa-initiates-coverage-on-radico-khaitan-stock-with-outperform-rating-by-investing.com

CLSA initiates coverage on Radico Khaitan stock with Outperform rating By Investing.com

Jul 29, 2025

CLSA initiates coverage on Radico Khaitan stock with Outperform rating

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 183
  6. 184
  7. 185
  8. 186
  9. 187
  10. 188
  11. 189
  12. ...
  13. 399
  14. »

Posts pagination

Newer posts Page 1 … Page 186 … Page 399 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.